| CAS NO: | 1358715-18-0 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Fuzuopali (SHR3162; Fluzoparib; Fuzuloparib) is a potent PARP [poly (ADP-ribose) polymerase] inhibitor with the potential for the treatment of solid tumours. It has been approved in China for recurrent ovarian cancer.
纯度：≥98%
CAS：1358715-18-0
m.cnreagent.com